1
|
Prieve MG, Harvie P, Monahan SD, Roy D, Li AG, Blevins TL, Paschal AE, Waldheim M, Bell EC, Galperin A, Ella-Menye JR, Houston ME. Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency. Mol Ther 2018; 26:801-813. [PMID: 29433939 PMCID: PMC5910669 DOI: 10.1016/j.ymthe.2017.12.024] [Citation(s) in RCA: 80] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2017] [Revised: 12/21/2017] [Accepted: 12/28/2017] [Indexed: 11/18/2022] Open
Abstract
We describe a novel, two-nanoparticle mRNA delivery system and show that it is highly effective as a means of intracellular enzyme replacement therapy (i-ERT) using a murine model of ornithine transcarbamylase deficiency (OTCD). Our Hybrid mRNA Technology delivery system (HMT) comprises an inert lipid nanoparticle that protects the mRNA from nucleases in the blood as it distributes to the liver and a polymer micelle that targets hepatocytes and triggers endosomal release of mRNA. This results in high-level synthesis of the desired protein specifically in the liver. HMT delivery of human OTC mRNA normalizes plasma ammonia and urinary orotic acid levels, and leads to a prolonged survival benefit in the murine OTCD model. HMT represents a unique, non-viral mRNA delivery method that allows multi-dose, systemic administration for treatment of single-gene inherited metabolic diseases.
Collapse
Affiliation(s)
- Mary G Prieve
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA.
| | - Pierrot Harvie
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | - Sean D Monahan
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | - Debashish Roy
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | - Allen G Li
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | - Teri L Blevins
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | - Amber E Paschal
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | - Matt Waldheim
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | - Eric C Bell
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | - Anna Galperin
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| | | | - Michael E Houston
- PhaseRx, Inc., 410 W. Harrison Street, Suite 300, Seattle, WA 98119, USA
| |
Collapse
|
2
|
Aleksandrovich YS, Khubulava GG, Chupaeva OY, Naumov AB, Marchenko SP, Melashenko TB, Pshenisnov KV, Li AG. ACETAMINOPHEN ADMINISTERING IN ORDER TO OBLITERATE HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS IN NEONATES WITH EXTREMELY LOW BIRTH WEIGHT. Anesteziol Reanimatol 2016; 61:438-442. [PMID: 29894612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
BACKGROUND Patent ductus arteriosus (PDA) is one of the most common pathological conditions within the neonatal period Functioning of hemodynamically significant patent ductus arteriosus can cause a development ofvarious complications. This is why the earliest possible drug therapy or surgery is required in order to eliminate this fetal communication. THE AIM to study the efficacy and safety of acetaminophen administering to infants with low birth weight for medical obliteration of hemodynamically significant ductus arteriosus. MATERIALS AND METHODS The study included 16 infants with gestational age up to 29 weeks and birth weight less than 1200 g, the average birth weight was 980±230 g and gestation was 26,4±1,4 weeks. The average age of the observable patients at the moment of the beginning of the acetaminophen therapy was 56±6 h. Ductus arteriosus diameter was 3,75±1,25 mm. All the children underwent drug obliteration of the PDA through the intravenous acetaminophen administering. 15 mg / kg of the drug was given every 6 hours for three days. The full treatment course included 12 injections. RESULTS The expected effect (closing of the ductus arteriosus) was achieved in 14 (87.5%) children undergoing the drug therapy. Two children with the birth weight of 1000 g and 1200 g remained with the ductus arteriosus open, but the signs of the left heart volume overload decreased significantly. To achieve a clinical benefit, it took 11 injections of the drug, on average. The children with the ongoing therapy were receiving enteral nutrition with the standard dosages corresponding to their age. No complications of the urinary tract, gastrointestinal tract or haemostatic system were registered. CONCLUSION Using acetaminophenfor medical obliteration of the ductus arteriosus is a highly effective and safe method of treatment that has to be used in routine clinical practice. Dosing of the drug is easy to control and change, hence it is possible to cancel the drug administering as soon as the required result is achieved so as to minimize any complications.
Collapse
|
3
|
Marsilje TH, Pei W, Chen B, Lu W, Uno T, Jin Y, Jiang T, Kim S, Li N, Warmuth M, Sarkisova Y, Sun F, Steffy A, Pferdekamper AC, Li AG, Joseph SB, Kim Y, Liu B, Tuntland T, Cui X, Gray NS, Steensma R, Wan Y, Jiang J, Chopiuk G, Li J, Gordon WP, Richmond W, Johnson K, Chang J, Groessl T, He YQ, Phimister A, Aycinena A, Lee CC, Bursulaya B, Karanewsky DS, Seidel HM, Harris JL, Michellys PY. Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials. J Med Chem 2013; 56:5675-90. [DOI: 10.1021/jm400402q] [Citation(s) in RCA: 319] [Impact Index Per Article: 29.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Thomas H. Marsilje
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Wei Pei
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Bei Chen
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Wenshuo Lu
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Tetsuo Uno
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Yunho Jin
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Tao Jiang
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Sungjoon Kim
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Nanxin Li
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Markus Warmuth
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Yelena Sarkisova
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Frank Sun
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Auzon Steffy
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - AnneMarie C. Pferdekamper
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Allen G. Li
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Sean B. Joseph
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Young Kim
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Bo Liu
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Tove Tuntland
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Xiaoming Cui
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Nathanael S. Gray
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Ruo Steensma
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Yongqin Wan
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Jiqing Jiang
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Greg Chopiuk
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Jie Li
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - W. Perry Gordon
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Wendy Richmond
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Kevin Johnson
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Jonathan Chang
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Todd Groessl
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - You-Qun He
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Andrew Phimister
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Alex Aycinena
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Christian C. Lee
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Badry Bursulaya
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Donald S. Karanewsky
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - H. Martin Seidel
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Jennifer L. Harris
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| | - Pierre-Yves Michellys
- Genomics Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States
| |
Collapse
|
4
|
Su SM, Zeng XB, Li LF, Duan R, Bai LY, Li AG, Wang J, Jiang S. Arsenate reduction and methylation in the cells of Trichoderma asperellum SM-12F1, Penicillium janthinellum SM-12F4, and Fusarium oxysporum CZ-8F1 investigated with X-ray absorption near edge structure. J Hazard Mater 2012; 243:364-7. [PMID: 23122191 DOI: 10.1016/j.jhazmat.2012.09.061] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/16/2012] [Revised: 09/12/2012] [Accepted: 09/26/2012] [Indexed: 05/26/2023]
Abstract
Synchrotron radiation-based X-ray absorption near edge structure (XANES) was introduced to directly analysis chemical species of arsenic (As) in the cells of Trichoderma asperellum SM-12F1, Penicillium janthinellum SM-12F4, and Fusarium oxysporum CZ-8F1 capable of As accumulation and volatilisation. After exposure to As(V) of 500 mg L(-1) for 15 days, a total of 60.5% and 65.3% of the accumulated As in the cells of T. asperellum SM-12F1 and P. janthinellum SM-12F4, respectively, was As(III), followed by 31.3% and 32.4% DMA (dimethylarsinic acid), 8.3% and 2.3% MMA (monomethylarsonic acid), respectively. However, for F. oxysporum CZ-8F1, 54.5% of the accumulated As was As(III), followed by 37.8% MMA and 7.7% As(V). The reduction and methylation of As(V) formed As(III), MMA, and DMA as the primacy products, and the reduction of As(V) might be more easily processed than the methylation. These results will help to understanding the mechanisms of As detoxification and its future application in bioremediation.
Collapse
Affiliation(s)
- S M Su
- Institute of Environment and Sustainable Development in Agriculture, Chinese Academy of Agricultural Sciences/Key Laboratory of Agro-Environment, Ministry of Agriculture, Beijing, PR China.
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Zeng QS, Fang YZ, Lou HB, Gong Y, Wang XD, Yang K, Li AG, Yan S, Lathe C, Wu FM, Yu XH, Jiang JZ. Low-density to high-density transition in Ce75Al23Si2 metallic glass. J Phys Condens Matter 2010; 22:375404. [PMID: 21403196 DOI: 10.1088/0953-8984/22/37/375404] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Using in situ high-pressure x-ray diffraction (XRD), we observed a pressure-induced polyamorphic transition from the low-density amorphous (LDA) state to the high-density amorphous (HDA) state in Ce(75)Al(23)Si(2) metallic glass at about 2 GPa and 300 K. The thermal stabilities of both LDA and HDA metallic glasses were further investigated using in situ high-temperature and high-pressure XRD, which revealed different pressure dependences of the onset crystallization temperature (T(x)) between them with a turning point at about 2 GPa. Compared with Ce(75)Al(25) metallic glass, minor Si doping shifts the onset polyamorphic transition pressure from 1.5 to 2 GPa and obviously stabilizes both LDA and HDA metallic glasses with higher T(x) and changes their slopes dT(x)/dP. The results obtained in this work reveal another polyamorphous metallic glass system by minor alloying (e.g. Si), which could modify the transition pressure and also properties of LDA and HDA metallic glasses. The minor alloying effect reported here is valuable for the development of more polyamorphous metallic glasses, even multicomponent bulk metallic glasses with modified properties, which will trigger more investigations in this field and improve our understanding of polyamorphism and metallic glasses.
Collapse
Affiliation(s)
- Q S Zeng
- International Center for New-Structured Materials, Zhejiang University, Hangzhou, People's Republic of China.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Zhang J, Adrián FJ, Jahnke W, Cowan-Jacob SW, Li AG, Iacob RE, Sim T, Powers J, Dierks C, Sun F, Guo GR, Ding Q, Okram B, Choi Y, Wojciechowski A, Deng X, Liu G, Fendrich G, Strauss A, Vajpai N, Grzesiek S, Tuntland T, Liu Y, Bursulaya B, Azam M, Manley PW, Engen JR, Daley GQ, Warmuth M, Gray NS. Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature 2010; 463:501-6. [PMID: 20072125 DOI: 10.1038/nature08675] [Citation(s) in RCA: 448] [Impact Index Per Article: 32.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2009] [Accepted: 11/11/2009] [Indexed: 11/09/2022]
Abstract
In an effort to find new pharmacological modalities to overcome resistance to ATP-binding-site inhibitors of Bcr-Abl, we recently reported the discovery of GNF-2, a selective allosteric Bcr-Abl inhibitor. Here, using solution NMR, X-ray crystallography, mutagenesis and hydrogen exchange mass spectrometry, we show that GNF-2 binds to the myristate-binding site of Abl, leading to changes in the structural dynamics of the ATP-binding site. GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, when used in combination with the ATP-competitive inhibitors imatinib or nilotinib, suppressed the emergence of resistance mutations in vitro, displayed additive inhibitory activity in biochemical and cellular assays against T315I mutant human Bcr-Abl and displayed in vivo efficacy against this recalcitrant mutant in a murine bone-marrow transplantation model. These results show that therapeutically relevant inhibition of Bcr-Abl activity can be achieved with inhibitors that bind to the myristate-binding site and that combining allosteric and ATP-competitive inhibitors can overcome resistance to either agent alone.
Collapse
Affiliation(s)
- Jianming Zhang
- Dana-Farber Cancer Institute, Harvard Medical School, Department of Cancer Biology, Seeley G. Mudd Building 628, Boston, Massachusetts 02115, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Ward WK, Li AG, Siddiqui Y, Federiuk IF, Wang XJ. Increased expression of Interleukin-13 and connective tissue growth factor, and their potential roles during foreign body encapsulation of subcutaneous implants. J Biomater Sci Polym Ed 2008; 19:1065-72. [PMID: 18644231 DOI: 10.1163/156856208784909408] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The purpose of this study was to better understand whether interleukin-13 (IL-13) and connective tissue growth factor (CTGF) are highly expressed during foreign body encapsulation of subcutaneous devices. Mock biosensors were implanted into rats for three lengths of time (7-, 21- and 48-55 days) to address different stages of the foreign body response. Using quantitative real-time PCR and immunofluorescence, the expression of IL13, CTGF, collagen 1, decorin and fibronectin were measured in this tissue. IL-13, a product of Th2 cells, was highly expressed at all time points, with greatest expression at day 21. The IL-13 expression was paralleled by increased presence of T-cells at all time points. CTGF was also found to be more highly expressed in foreign body tissue than in controls. Collagen and decorin were highly expressed at the middle and later stages. Given the increased expression of IL-13 and CTGF in foreign body tissue, and their roles in other fibrotic disorders, these cytokines may well contribute to the formation of the foreign body capsule. Since the peak gene expression of IL-13 occurred later than the previously-reported TGFbeta expression peak, IL-13 is probably not the major stimulus to TGFbeta expression during foreign body encapsulation and may contribute to fibrosis independently.
Collapse
Affiliation(s)
- W Kenneth Ward
- Legacy Health System, 1225 NE 2nd Avenue, Portland, OR 97232, USA.
| | | | | | | | | |
Collapse
|
8
|
Owens P, Li AG, Wang XJ. 039
Constitutive TGFβ1 Overexpression in Mouse Keratinocytes Delays Cutaneous Wound Healing. Wound Repair Regen 2008. [DOI: 10.1111/j.1067-1927.2005.130215am.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
9
|
Hong S, Lim S, Li AG, Lee C, Lee YS, Lee EK, Park SH, Wang XJ, Kim SJ. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol 2007; 8:504-13. [PMID: 17384642 DOI: 10.1038/ni1451] [Citation(s) in RCA: 108] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2007] [Accepted: 02/20/2007] [Indexed: 01/01/2023]
Abstract
Transforming growth factor-beta1 (TGF-beta1) regulates inflammation and can inhibit activation of the transcription factor NF-kappaB in certain cell types. Here we show that the TGF-beta-induced signaling protein Smad7 bound to TAB2 and TAB3, which are adaptors that link the kinase TAK1 to 'upstream' regulators in the proinflammatory tumor necrosis factor (TNF) signaling pathway. Smad7 thereby promoted TGF-beta-mediated anti-inflammatory effects. The formation of Smad7-TAB2 and Smad7-TAB3 complexes resulted in the suppression of TNF signaling through the adaptors TRAF2, TAB2 and/or TAB3, and TAK1. Furthermore, expression of a transgene encoding Smad7 in mouse skin suppressed inflammation and NF-kappaB nuclear translocation substantially and disrupted the formation of endogenous TRAF2-TAK1-TAB2 and TRAF2-TAK1-TAB3 complexes. Thus, Smad7 is a critical mediator of TGF-beta signals that block proinflammatory TNF signals.
Collapse
Affiliation(s)
- Suntaek Hong
- Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892-50551, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Tan MG, Zhang GL, Li XL, Zhang YX, Yue WS, Chen JM, Wang YS, Li AG, Li Y, Zhang YM, Shan ZC. Comprehensive study of lead pollution in Shanghai by multiple techniques. Anal Chem 2007; 78:8044-50. [PMID: 17134138 DOI: 10.1021/ac061365q] [Citation(s) in RCA: 125] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Aerosol samples of PM10 particulates were examined with particle-induced X-ray emission (PIXE and micro-PIXE ), inductively coupled plasma-mass spectrometry, and X-ray absorption fine structures (XAFS) to investigate atmospheric Pb concentrations and its chemical species and to decide the source assignment. From the elemental analyses, lead concentrations were averaged at 369 and 237 ng.m-3 in aerosol samples of PM10 collected from 19 monitor sites in Shanghai in the winter of 2002 and 2003, respectively. The XAFS results show that major chemical forms of the lead particulates are probably PbCl2, PbSO4, and PbO. A calculation of isotope ratio and chemical mass balance of the PM10 samples revealed that the atmospheric lead particulates in Shanghai in the two periods were mainly from coal combustors, iron and steel plants, and automobile exhausts, with coal combustion dominating the lead pollution after the phasing out of leaded gasoline in 1997 in Shanghai.
Collapse
Affiliation(s)
- M G Tan
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Li AG, Quinn MJ, Siddiqui Y, Wood MD, Federiuk IF, Duman HM, Ward WK. Elevation of transforming growth factor beta (TGFβ) and its downstream mediators in subcutaneous foreign body capsule tissue. J Biomed Mater Res A 2007; 82:498-508. [PMID: 17295253 DOI: 10.1002/jbm.a.31168] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Foreign body encapsulation represents a chronic fibrotic response and has been a major obstacle that reduces the useful life of implanted biomedical devices. The precise mechanism underlying such an encapsulation is still unknown. We hypothesized that, considering its central role in many other fibrotic conditions, transforming growth factor beta (TGFbeta) may play an important role during the formation of foreign body capsule (FBC). In the present study, we implanted mock sensors in rats subcutaneously and excised FBC samples at day 7, 21, and 48-55 postimplantation. The most abundant TGFbeta isoform in all tissues was TGFbeta1, which was expressed minimally in control tissue. The expression of both TGFbeta1 RNA and protein was significantly increased in FBC tissues at all time points, with the highest level in day 7 FBC. The number of cells stained for phosphorylated Smad2, an indication of activated TGFbeta signaling, paralleled the expression of TGFbeta. A similar dynamic change was also observed in the numbers of FBC myofibroblasts, which in response to TGFbeta, differentiate from quiescent fibroblasts and synthesize collagen. Type I collagen, the most prominent downstream target of TGFbeta in fibrosis, was found in abundance in the FBC, especially during the latter time periods. We suggest that TGFbeta plays an important role in the FBC formation. Inhibition of TGFbeta signaling could be a promising strategy in the prevention of FBC formation, thereby extending the useful life of subcutaneous implants.
Collapse
Affiliation(s)
- Allen G Li
- Department of Dermatology, Oregon Health and Science University, Portland, Oregon 97239, USA
| | | | | | | | | | | | | |
Collapse
|
12
|
Han G, Li AG, Liang YY, Owens P, He W, Lu S, Yoshimatsu Y, Wang D, Ten Dijke P, Lin X, Wang XJ. Smad7-induced beta-catenin degradation alters epidermal appendage development. Dev Cell 2006; 11:301-12. [PMID: 16950122 DOI: 10.1016/j.devcel.2006.06.014] [Citation(s) in RCA: 118] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2006] [Revised: 05/22/2006] [Accepted: 06/28/2006] [Indexed: 12/12/2022]
Abstract
To assess whether Smad signaling affects skin development, we generated transgenic mice in which a Smad antagonist, Smad7, was induced in keratinocytes, including epidermal stem cells. Smad7 transgene induction perturbed hair follicle morphogenesis and differentiation, but accelerated sebaceous gland morphogenesis. Further analysis revealed that independent of its role in anti-Smad signaling, Smad7 bound beta-catenin and induced beta-catenin degradation by recruiting an E3 ligase, Smurf2, to the Smad7/beta-catenin complex. Consequently, Wnt/beta-catenin signaling was suppressed in Smad7 transgenic hair follicles. Coexpression of the Smurf2 and Smad7 transgenes exacerbated Smad7-induced abnormalities in hair follicles and sebaceous glands. Conversely, when endogenous Smad7 was knocked down, keratinocytes exhibited increased beta-catenin protein and enhanced Wnt signaling. Our data reveal a mechanism for Smad7 in antagonizing Wnt/beta-catenin signaling, thereby shifting the skin differentiation program from forming hair follicles to sebaceous glands.
Collapse
Affiliation(s)
- Gangwen Han
- Department of Otolaryngology, Oregon Health & Science University, Portland, 97239, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Lu SL, Herrington H, Reh D, Weber S, Bornstein S, Wang D, Li AG, Tang CF, Siddiqui Y, Nord J, Andersen P, Corless CL, Wang XJ. Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev 2006; 20:1331-42. [PMID: 16702406 PMCID: PMC1472907 DOI: 10.1101/gad.1413306] [Citation(s) in RCA: 168] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
The prognosis of head-and-neck squamous cell carcinoma (HNSCC) has not been improved in the past 20 years. Validation of HNSCC biomarkers for targeted therapy has been hindered by a lack of animal models mimicking human HNSCC at both the pathological and molecular levels. Here we report that overexpression of K-ras or H-ras and loss of transforming growth factor-beta type II receptor (TGFbetaRII) are common events in human HNSCC. Activation of either K-ras or H-ras in combination with TGFbetaRII deletion from mouse head-and-neck epithelia caused HNSCC with complete penetrance, some of which progressed to metastases. These tumors displayed pathology indistinguishable from human HNSCCs and exhibited multiple molecular alterations commonly found in human HNSCCs. Additionally, elevated endogenous TGFbeta1 in these lesions contributed to inflammation and angiogenesis. Our data suggest that targeting common oncogenic pathways in tumor epithelia together with blocking the effect of TGFbeta1 on tumor stroma may provide a novel therapeutic strategy for HNSCC.
Collapse
Affiliation(s)
- Shi-Long Lu
- Department of Otolaryngology, OHSU Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Abstract
Smad4 is the common mediator for TGFbeta signals, which play important functions in many biological processes. To study the role of Smad4 in skin development and epidermal tumorigenesis, we disrupted this gene in skin using the Cre-loxP approach. We showed that absence of Smad4 blocked hair follicle differentiation and cycling, leading to a progressive hair loss of mutant (MT) mice. MT hair follicles exhibited diminished expression of Lef1, and increased proliferative cells in the outer root sheath. Additionally, the skin of MT mice exhibited increased proliferation of basal keratinocytes and epidermal hyperplasia. Furthermore, we provide evidence that the absence of Smad4 resulted in a block of both TGFbeta and bone morphogenetic protein (BMP) signaling pathways, including p21, a well-known cyclin-dependent kinase inhibitor. Consequently, all MT mice developed spontaneous malignant skin tumors from 3 months to 13 months of age. The majority of tumors are malignant squamous cell carcinomas. A most notable finding is that tumorigenesis is accompanied by inactivation of phosphatase and tensin homolog deleted on chromosome 10 (Pten), activation of AKT, fast proliferation and nuclear accumulation of cyclin D1. These observations revealed the essential functions of Smad4-mediated signals in repressing skin tumor formation through the TGFbeta/BMP pathway, which interacts with the Pten signaling pathway.
Collapse
Affiliation(s)
- W Qiao
- Genetics of Development and Disease Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
| | | | | | | | | | | |
Collapse
|
15
|
Han G, Lu SL, Li AG, He W, Corless CL, Kulesz-Martin M, Wang XJ. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 2005; 115:1714-23. [PMID: 15937546 PMCID: PMC1142114 DOI: 10.1172/jci24399] [Citation(s) in RCA: 193] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2005] [Accepted: 04/19/2005] [Indexed: 12/18/2022] Open
Abstract
In the present study, we demonstrated that human skin cancers frequently overexpress TGF-beta1 but exhibit decreased expression of the TGF-beta type II receptor (TGF-(beta)RII). To understand how this combination affects cancer prognosis, we generated a transgenic mouse model that allowed inducible expression of TGF-beta(1) in keratinocytes expressing a dominant negative TGF-(beta)RII (Delta(beta)RII) in the epidermis. Without Delta(beta)RII expression, TGF-beta1 transgene induction in late-stage, chemically induced papillomas failed to inhibit tumor growth but increased metastasis and epithelial-to-mesenchymal transition (EMT), i.e., formation of spindle cell carcinomas. Interestingly, Delta(beta)RII expression abrogated TGF-beta1-mediated EMT and was accompanied by restoration of membrane-associated E-cadherin/catenin complex in TGF-beta1/Delta(beta)RII compound tumors. Furthermore, expression of molecules thought to mediate TGF-beta1-induced EMT was attenuated in TGF-beta1/Delta(beta)RII-transgenic tumors. However, TGF-beta1/Delta(beta)RII-transgenic tumors progressed to metastasis without losing expression of the membrane-associated E-cadherin/catenin complex and at a rate higher than those observed in nontransgenic, TGF-beta1-transgenic, or Delta(beta)RII-transgenic mice. Abrogation of Smad activation by Delta(beta)RII correlated with the blockade of EMT. However, Delta(beta)RII did not alter TGF-beta1-mediated expression of RhoA/Rac and MAPK, which contributed to increased metastasis. Our study provides evidence that TGF-beta1 induces EMT and invasion via distinct mechanisms. TGF-beta1-mediated EMT requires functional TGF-(beta)RII, whereas TGF-beta1-mediated tumor invasion cooperates with reduced TGF-(beta)RII signaling in tumor epithelia.
Collapse
Affiliation(s)
- Gangwen Han
- Department of Otolaryngology, Oregon Health & Science University, Portland, OR, USA
| | | | | | | | | | | | | |
Collapse
|
16
|
Wang W, Huang XR, Li AG, Liu F, Li JH, Truong LD, Wang XJ, Lan HY. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005; 16:1371-83. [PMID: 15788474 DOI: 10.1681/asn.2004121070] [Citation(s) in RCA: 202] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
TGF-beta has been shown to play a critical role in anti-inflammation; however, the signaling mechanisms of TGF-beta in anti-inflammatory response remains largely unclear. This study reported that mice that overexpress latent TGF-beta1 on skin are protected against renal inflammation in a model of obstructive kidney disease and investigated the signaling mechanism of TGF-beta1 in inhibition of renal inflammation in vivo and in vitro. Seven days after urinary obstruction, wild-type mice developed severe renal inflammation, including massive T cell and macrophage infiltration and marked upregulation of IL-1beta, TNF-alpha, and intercellular adhesion molecule-1 (all P < 0.001). Surprising, renal inflammation was prevented in transgenic mice. This was associated with an increase in latent TGF-beta1 in circulation (a 10-fold increase) and renal tissues (a 2.5-fold increase). Further studies showed that inhibition of renal inflammation in TGF-beta1 transgenic mice was also associated with a marked upregulation of renal Smad7 and IkappaBalpha and a suppression of NF-kappaB activation in the diseased kidney (all P < 0.01). These in vivo findings suggested the importance of TGF-beta-NF-kappaB cross-talk signaling pathway in regulating renal inflammation. This was tested in vitro in a doxycycline-regulated Smad7-expressing renal tubular cell line. Overexpression of Smad7 was able to upregulate IkappaBalpha directly in a time- and dose-dependent manner, thereby inhibiting NF-kappaB activation and NF-kappaB-driven inflammatory response. In conclusion, latent TGF-beta may have protective roles in renal inflammation. Smad7-mediated inhibition of NF-kappaB activation via the induction of IkBalpha may be the central mechanism by which latent TGF-beta prevents renal inflammation.
Collapse
Affiliation(s)
- Wansheng Wang
- Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Alkek N520, Houston, Texas 77030, USA
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Abstract
It has been shown that Smad3 exerts both tumor-suppressive and -promoting roles. To evaluate the role of Smad3 in skin carcinogenesis in vivo, we applied a chemical skin carcinogenesis protocol to Smad3 knockout mice (Smad3(-/-) and Smad3(+/-)) and wild-type littermates (Smad3(+/+)). Smad3(-/-) mice exhibited reduced papilloma formation in comparison with Smad3(+/+) mice and did not develop any squamous cell carcinomas. Further analysis revealed that Smad3 knockout mice were resistant to 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced epidermal hyperproliferation. Concurrently, increased apoptosis was observed in TPA-treated Smad3(-/-) skin and papillomas when compared with those of wild-type mice. Expression levels of activator protein-1 family members (c-jun, junB, junD, and c-fos) and transforming growth factor (TGF)-alpha were significantly lower in TPA-treated Smad3(-/-) skin, cultured keratinocytes, and papillomas, as compared with Smad3(+/+) controls. Smad3(-/-) papillomas also exhibited reduced leukocyte infiltration, particularly a reduction of tumor-associated macrophage infiltration, in comparison with Smad3(+/+) papillomas. All of these molecular and cellular alterations also occurred to a lesser extent in Smad3(+/-) mice as compared with Smad3(+/+) mice, suggesting a Smad3 gene dosage effect. Given that TGF-beta1 is a well-documented TPA-responsive gene and also has a potent chemotactic effect on macrophages, our study suggests that Smad3 may be required for TPA-mediated tumor promotion through inducing TGF-beta1-responsive genes, which are required for tumor promotion, and through mediating TGF-beta1-induced macrophage infiltration.
Collapse
Affiliation(s)
- Allen G Li
- Department of Otolaryngology, Oregon Health and Science University, Portland, Oregon, USA
| | | | | | | | | |
Collapse
|
18
|
Lu SL, Reh D, Li AG, Woods J, Corless CL, Kulesz-Martin M, Wang XJ. Overexpression of Transforming Growth Factor β1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation. Cancer Res 2004; 64:4405-10. [PMID: 15231647 DOI: 10.1158/0008-5472.can-04-1032] [Citation(s) in RCA: 157] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In the present study, we show that transforming growth factor beta1 (TGF-beta1) was frequently overexpressed in human head and neck squamous cell carcinomas (HNSCCs) and adjacent tissues in comparison with normal head and neck tissues. To determine the role of TGF-beta1 overexpression in HNSCC carcinogenesis, we generated transgenic mice in which TGF-beta1 transgene expression can be induced in head and neck epithelia. TGF-beta1 transgene induction in head and neck epithelia, at levels similar to those in human HNSCCs, caused severe inflammation and angiogenesis. Consequently, TGF-beta1-transgenic epithelia exhibited hyperproliferation. These phenotypes correlated with enhanced Smad signaling in transgenic epithelia and stroma. Our study suggests that TGF-beta1 overexpression at early stages of HNSCC formation provides a tumor promoting microenvironment.
Collapse
Affiliation(s)
- Shi-Long Lu
- Department of Otolaryngology, Oregon Health & Science University, Portland, USA
| | | | | | | | | | | | | |
Collapse
|
19
|
Li AG, Wang D, Feng XH, Wang XJ. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J 2004; 23:1770-81. [PMID: 15057277 PMCID: PMC394237 DOI: 10.1038/sj.emboj.7600183] [Citation(s) in RCA: 166] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2003] [Accepted: 03/03/2004] [Indexed: 01/16/2023] Open
Abstract
Transforming growth factor beta1 (TGFbeta1), a potent keratinocyte growth inhibitor, has been shown to be overexpressed in keratinocytes in certain inflammatory skin diseases and has been thought to counteract the effects of other growth factors at the site of inflammation. Surprisingly, our transgenic mice expressing wild-type TGFbeta1 in the epidermis using a keratin 5 promoter (K5.TGFbeta1(wt)) developed inflammatory skin lesions, with gross appearance of psoriasis-like plaques, generalized scaly erythema, and Koebner's phenomenon. These lesions were characterized by epidermal hyperproliferation, massive infiltration of neutrophils, T lymphocytes, and macrophages to the epidermis and superficial dermis, subcorneal microabscesses, basement membrane degradation, and angiogenesis. K5.TGFbeta1(wt) skin exhibited multiple molecular changes that typically occur in human Th1 inflammatory skin disorders, such as psoriasis. Further analyses revealed enhanced Smad signaling in transgenic epidermis and dermis. Our study suggests that certain pathological condition-induced TGFbeta1 overexpression in the skin may synergize with or induce molecules required for the development of Th1 inflammatory skin disorders.
Collapse
Affiliation(s)
- Allen G Li
- Departments of Otolaryngology, Dermatology, Cell and Developmental Biology, Oregon Health & Science University, Portland, OR, USA
| | - Donna Wang
- Departments of Otolaryngology, Dermatology, Cell and Developmental Biology, Oregon Health & Science University, Portland, OR, USA
| | - Xin-Hua Feng
- Departments of Surgery, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA
| | - Xiao-Jing Wang
- Departments of Otolaryngology, Dermatology, Cell and Developmental Biology, Oregon Health & Science University, Portland, OR, USA
- Mail code R&D 46, VAMC Bldg. 103, Rm. F-221, 3710 SW US Veterans Hospital Road, Portland, OR 97239, USA. Tel.: +1 503 220 8262x54273; Fax: +1 503 402 2817; E-mail:
| |
Collapse
|
20
|
Ming Kwan K, Li AG, Wang XJ, Wurst W, Behringer RR. Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Genesis 2004; 39:10-25. [PMID: 15124223 DOI: 10.1002/gene.20021] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Hair differentiation and growth are controlled by complex reciprocal signaling between epithelial and mesenchymal cells. To better understand the requirement and molecular mechanism of BMP signaling in hair follicle development, we performed genetic analyses of bone morphogenetic protein receptor 1A (BMPR-IA) function during hair follicle development by using a conditional knockout approach. The conditional mutation of Bmpr1a in ventral limb ectoderm and its derivatives (epidermis and hair follicles) resulted in a lack of hair outgrowth from the affected skin regions. Mutant hair follicles exhibited abnormal morphology and lacked hair formation and pigment deposition during anagen. The timing of the hair cycle and the proliferation of hair matrix cells were also affected in the mutant follicles. We demonstrate that signaling via epithelial BMPR-IA is required for differentiation of both hair shaft and inner root sheath from hair matrix precursor cells in anagen hair follicles but is dispensable for embryonic hair follicle induction. Surprisingly, aberrant de novo hair follicle morphogenesis together with hair matrix cell hyperplasia was observed in the absence of BMPR-IA signaling within the affected skin of adult mutants. They developed hair follicle tumors from 3 months of age, indicating that inactivation of epidermal BMPR-IA signaling can lead to hair tumor formation. Taken together, our data provide genetic evidence that BMPR-IA signaling plays critical and multiple roles in controlling cell fate decisions or maintenance, proliferation, and differentiation during hair morphogenesis and growth, and implicate Bmpr1a as a tumor suppressor in skin tumorigenesis.
Collapse
Affiliation(s)
- Kin Ming Kwan
- Department of Molecular Genetics, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
| | | | | | | | | |
Collapse
|
21
|
Abstract
The transforming growth factor beta (TGFbeta) superfamily encompasses a number of structurally related proteins that can be divided into several subfamilies including TGFbetas, activins/inhibins and bone morphogenetic proteins (BMPs). The Smads are major intracellular mediators in transducing the signals of TGFbeta superfamily members, and are abundantly expressed in the developing epidermis and epidermal appendages. Moreover, the phenotypes of transgenic/knockout mice with altered components of the TGFbeta superfamily signaling pathway suggest that TGFbeta superfamily signaling is required for epidermal/appendage development. TGFbeta superfamily members are involved in most events during epidermal/appendage development through the TGFbeta signal transduction pathway and through cross talk with other signaling pathways. Future studies will be instrumental in defining the precise roles for TGFbeta superfamily signaling in epidermal/appendage development.
Collapse
Affiliation(s)
- Allen G Li
- Department of Dermatology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
| | | | | |
Collapse
|
22
|
He W, Li AG, Wang D, Han S, Zheng B, Goumans MJ, ten Dijke P, Wang XJ. Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J 2002; 21:2580-90. [PMID: 12032071 PMCID: PMC126032 DOI: 10.1093/emboj/21.11.2580] [Citation(s) in RCA: 85] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Biochemical studies have shown that Smad7 blocks signal transduction of transforming growth factor beta (TGFbeta); however, its in vivo functions are largely unknown. To determine the functions of Smad7, we have expressed Smad7 in transgenic mice, utilizing a keratin K5 promoter (K5.Smad7). K5.Smad7 mice exhibited pathological changes in multiple tissues and died within 10 days after birth. These mice were born with open eyelids and corneal defects, significantly delayed and aberrant hair follicle morphogenesis, and hyperproliferation in the epidermis and other stratified epithelia. Furthermore, K5.Smad7 mice developed severe thymic atrophy and massive thymocyte death, suggesting that Smad signaling in thymic epithelia is essential for thymocyte survival. Interestingly, in addition to a reduction in Smad phosphorylation, the protein levels of the receptors for TGFbeta, activin and bone morphogenetic protein were significantly decreased in the affected tissues of K5.Smad7 mice. Our study provides evidence that Smad7 is a potent in vivo inhibitor for signal transduction of the TGFbeta superfamily during development and maintenance of homeostasis of multiple epithelial tissues.
Collapse
Affiliation(s)
- Wei He
- Departments of
Dermatology, Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding author e-mail:
| | - Allen G. Li
- Departments of
Dermatology, Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding author e-mail:
| | - Dongyan Wang
- Departments of
Dermatology, Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding author e-mail:
| | - Shuhua Han
- Departments of
Dermatology, Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding author e-mail:
| | - Biao Zheng
- Departments of
Dermatology, Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding author e-mail:
| | - Marie-José Goumans
- Departments of
Dermatology, Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding author e-mail:
| | - Peter ten Dijke
- Departments of
Dermatology, Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding author e-mail:
| | - Xiao-Jing Wang
- Departments of
Dermatology, Immunology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA and Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding author e-mail:
| |
Collapse
|
23
|
Windsor AC, Kanwar S, Li AG, Barnes E, Guthrie JA, Spark JI, Welsh F, Guillou PJ, Reynolds JV. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42:431-5. [PMID: 9577354 PMCID: PMC1727034 DOI: 10.1136/gut.42.3.431] [Citation(s) in RCA: 396] [Impact Index Per Article: 15.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND In patients with major trauma and burns, total enteral nutrition (TEN) significantly decreases the acute phase response and incidence of septic complications when compared with total parenteral nutrition (TPN). Poor outcome in acute pancreatitis is associated with a high incidence of systemic inflammatory response syndrome (SIRS) and sepsis. AIMS To determine whether TEN can attenuate the acute phase response and improve clinical disease severity in patients with acute pancreatitis. METHODS Glasgow score, Apache II, computed tomography (CT) scan score, C reactive protein (CRP), serum IgM antiendotoxin antibodies (EndoCAb), and total antioxidant capacity (TAC) were determined on admission in 34 patients with acute pancreatitis. Patients were stratified according to disease severity and randomised to receive either TPN or TEN for seven days and then re-evaluated. RESULTS SIRS, sepsis, organ failure, and ITU stay, were globally improved in the enterally fed patients. The acute phase response and disease severity scores were significantly improved following enteral nutrition (CRP: 156 (117-222) to 84 (50-141), p < 0.005; APACHE II scores 8 (6-10) to 6 (4-8), p < 0.0001) without change in the CT scan scores. In parenterally fed patients these parameters did not change but there was an increase in EndoCAb antibody levels and a fall in TAC. Enterally fed patients showed no change in the level of EndoCAb antibodies and an increase in TAC. CONCLUSION TEN moderates the acute phase response, and improves disease severity and clinical outcome despite unchanged pancreatic injury on CT scan. Reduced systemic exposure to endotoxin and reduced oxidant stress also occurred in the TEN group. Enteral feeding modulates the inflammatory and sepsis response in acute pancreatitis and is clinically beneficial.
Collapse
Affiliation(s)
- A C Windsor
- Department of Surgery, St James's University Hospital, Leeds, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Li AG. [Comparative study of methods of active effects on human brain to reveal abilities of low level perception]. Biofizika 1997; 42:711-717. [PMID: 9296632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Active methods of the influence upon the person with the aim of forming special states of the brain in order to obtain reproducible and strong perception of low level signals are compared. If the human brain is immediately exposed to the force by penetrating physical fields (i.e. magnetic, electromagnetic, acoustic) than best results can be obtained while using electromagnetic and acoustic fields; in this case the effectiveness of the tests on perception grows from (50 +/- 6) to (79 +/- 9)%. If the brain is forced through the peripheral sensory systems (visual and acoustic analyzers and skin receptors) than perception grows from (50 +/- 6) to (85 +/- 10)%. Special device for influence upon the brain through visual analyzer with the help of bylatheral photo-stimulation is described. The outlook of the control upon special states of brain with the aim to reveal abilities to the low level perception is discussed.
Collapse
|
25
|
Chunovkina AG, Li AG. [A statistic approach to interpretation, results processing and hypo thesis testing in experiments on exposuring the human brain to perception of low level signals]. Biofizika 1997; 42:718-24. [PMID: 9296633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
There are shown the limitations of using the generally accepted approaches to statistic data processing at the perception of low level signals on Bernully scheme when specific nature on the phenomenon (the human ability to perception is not constant, uncontrolled and manifests itself for a short time) isn't taken into account. A new approach to the statistic processing of measurement results is also proposed. It is based on the sequence analysis of correct answers in a series, the use of sequential statistic procedures (criteria), maximally taking into account the perception specificity and the measurement features. The estimate of first kind error in proposed method has been carried out.
Collapse
|
26
|
Li AG, He SL, Pen YG. [Effect of buyang huanwu decoction on the antithrombotic functions of the vessel wall]. Zhong Xi Yi Jie He Za Zhi 1989; 9:545-7, 517. [PMID: 2598361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The effects of Buyang Huanwu Decoction (BYHWD) on the antithrombotic functions of vessel wall were studied with human umbilical vein perfusion. It was observed that the both of Von Willebrand factor release stimulated by thrombin from the vessel walls and conversion of fibrinogen to fibrin catalyzed by thrombin were inhibited by BYHWD. There were no obvious effects of BYHWD on the thrombin adsorption to the vessel walls and the thrombin induced release of PGI2 as well as fibrinolysis inhibiting activity from the vessel walls.
Collapse
|